¸Þµð¾÷

´ëÇк´¿ø Çѹ溴¿ø
Á¾ÇÕº´¿ø ³ëÀκ´¿ø
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹Á¤º¸
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ëºÐ¾ç¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
¸ÞµðÅå
´ëÇк´¿ø Á¾ÇÕº´¿ø Çѹ溴¿ø Ä¡°úº´¿ø ÇÑÀÇ¿ø ³ëÀÎÀü¹®º´¿ø º¸°Ç¼Ò
¼­¿ï ºÎ»ê ÀÎõ ´ë±¸ ´ëÀü ±¤ÁÖ ¿ï»ê °æ±â °­¿ø ÃæºÏ Ãæ³² °æºÏ °æ³² ÀüºÏ Àü³² Á¦ÁÖ ¼¼Á¾
Ä¡°ú ¾È°ú ÇǺΰú ¼ºÇü¿Ü°ú »êºÎÀΰú ºñ´¢±â°ú ¿Ü°ú ³»°ú Á¤Çü¿Ü°ú À̺ñÀÎÈÄ°ú ¼Ò¾Æ°ú ¾à±¹

¸ñ·Ï ¼öÁ¤ »èÁ¦

2020 Á¦39ȸ ´ëÇÑÁ¤¸ÆÇÐȸ Ãß°èÇмú´ëȸ : 2020-11-08

ÃßõÇϱâ
¿¬¼ö°­Á À̹øÁÖ BEST
 
2020 Á¦39ȸ ´ëÇÑÁ¤¸ÆÇÐȸ Ãß°èÇмú´ëȸ : 2020-11-08
±³À°ÀÏÀÚ : 2020-11-08
±³À°Àå¼Ò : ¼­¿ïµå·¡°ï½ÃƼ  
±³À°ÁÖÁ¦ : 2020 Á¦39ȸ ´ëÇÑÁ¤¸ÆÇÐȸ Ãß°èÇмú´ëȸ      
ÁÖÃÖ±â°ü : ´ëÇÑÇ÷°ü¿Ü°úÇÐȸ
½ÃÇà±â°ü(ÁöºÎ/°ú) : ´ëÇÑÁ¤¸ÆÇÐȸ  
´ã´çÀÚ : ´ëÇÑÁ¤¸ÆÇÐȸ
¿¬¶ôó : 02-3446-9180  
À̸ÞÀÏ : ksp@koreavein.or.kr      
±³À°Á¾·ù : ¿Ü°ú      
Âü¼®¿¹»óÀοø : 200¸í
Èñ¸ÁÆòÁ¡ : 5Á¡  
Áö¿ª : ¼­¿ïƯº°½Ã
±³À°½Ã°£ : 5 ½Ã°£ 0ºÐ  
¼¼ºÎ¼ö°­·á : 40,000¿ø      
ºñ°í Á¤È¸¿ø: 2¸¸¿ø Àü¹®ÀÇ/ ÀϹÝÀÇ/ °³¿øÀÇ: 4¸¸¿ø ÁÂÀå/¿¬ÀÚ/ Àü°øÀÇ/ºñÀü¹®ÀÇ/ÆгÎ: ¸éÁ¦      
       
±¸ºÐ ¿ùÀÏ °­ÀǽǠ½Ã°£ ±³À°Á¦¸ñ  °­»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±âŸ 11¿ù 08ÀÏ  08:30~08:55 Registration  () 
±âŸ 11¿ù 08ÀÏ ±×·£µåº¼·ë 08:55~09:00 Opening Address  À±»ó¼·(´ëÇÑÁ¤¸ÆÇÐȸ ÀÌ»çÀå) 
±³À°½Ã°£ 11¿ù 08ÀÏ ±×·£µåº¼·ë 09:00~09:10 Venous aneurysm, its evaluation and treatment  È²È«ÇÊ(ÀüºÏ´ëº´¿ø) 
±³À°½Ã°£ 11¿ù 08ÀÏ ±×·£µåº¼·ë 09:10~09:20 The latest update on history of iliac stenting  ÃÖÂùÁß(Ãæ³²´ëº´¿ø) 
±³À°½Ã°£ 11¿ù 08ÀÏ ±×·£µåº¼·ë 09:20~09:30 Diagnostic modalities of pelvic congestion syndrome  ±è°Ç¿ì(¹ÎÆ®º´¿ø) 
±³À°½Ã°£ 11¿ù 08ÀÏ ±×·£µåº¼·ë 09:30~09:40 The latest update on history of foam therapy  À̽Âö(Æí¾ÈÇÏÁöÈäºÎ¿Ü°ú) 
Åä·Ð 11¿ù 08ÀÏ ±×·£µåº¼·ë 09:40~09:50 Discussion  À̽Âö(Æí¾ÈÇÏÁöÈäºÎ¿Ü°ú) 
È޽Ġ11¿ù 08ÀÏ ±×·£µåº¼·ë 09:50~10:10 Coffee Break  () 
±³À°½Ã°£ 11¿ù 08ÀÏ ±×·£µåº¼·ë 10:10~10:20 Neurovascular structures at risk with the operation for varicose veins  ±èÇâ°æ(¼­¿ï¾Æ»êº´¿ø) 
±³À°½Ã°£ 11¿ù 08ÀÏ ±×·£µåº¼·ë 10:20~10:30 Recorded live + Q&A  ±èÇâ°æ(¼­¿ï¾Æ»êº´¿ø) 
±³À°½Ã°£ 11¿ù 08ÀÏ ±×·£µåº¼·ë 10:30~10:40 Lower extremity venous reflux; Truncal vein  ¹é°­¼®(¼­¿ïÀÇ·á¿ø) 
±³À°½Ã°£ 11¿ù 08ÀÏ ±×·£µåº¼·ë 10:40~10:50 Recorded live + Q&A  ¹é°­¼®(¼­¿ïÀÇ·á¿ø) 
±³À°½Ã°£ 11¿ù 08ÀÏ ±×·£µåº¼·ë 10:50~11:00 Lower extremity venous reflux; Perforator vein  Á¶ÁøÇö(°­µ¿°æÈñ´ëº´¿ø) 
±³À°½Ã°£ 11¿ù 08ÀÏ ±×·£µåº¼·ë 11:00~11:10 Recorded live + Q&A  Á¶ÁøÇö(°­µ¿°æÈñ´ëº´¿ø) 
±³À°½Ã°£ 11¿ù 08ÀÏ ±×·£µåº¼·ë 11:10~12:00 Free Papers  È«±âÇ¥(±¹¹Î°Ç°­º¸Çè Àϻ꺴¿ø) 
±³À°½Ã°£ 11¿ù 08ÀÏ ±×·£µåº¼·ë 12:10~12:30 Which drug is the real MPFF?  ±è¼ÛÀÌ(¼¼Á¾Ãæ³²´ëº´¿ø) 
±âŸ 11¿ù 08ÀÏ ±×·£µåº¼·ë 12:50~13:10 ÃÑȸ  () 
±âŸ 11¿ù 08ÀÏ ±×·£µåº¼·ë 13:10~13:30 ¿¬±¸ºñ °¨»çÆÐ ÁõÁ¤ ¹× »çÁø ÃÔ¿µ  () 
±³À°½Ã°£ 11¿ù 08ÀÏ ±×·£µåº¼·ë 13:50~14:00 Postprocedural evaluations of radiofrequency ablation(RFA)  ±èµ¿Çõ(¼ö¿øǪ¸¥¸Æ¿Ü°ú) 
±³À°½Ã°£ 11¿ù 08ÀÏ ±×·£µåº¼·ë 14:00~14:10 Recorded live + Q&A  ±èµ¿Çõ(¼ö¿øǪ¸¥¸Æ¿Ü°ú) 
±³À°½Ã°£ 11¿ù 08ÀÏ ±×·£µåº¼·ë 14:10~14:20 Postprocedural evaluations of endovenous laser ablation(EVLA)  Á¤¿µ±Õ(±¸¹Ì¼öÈäºÎ¿Ü°ú) 
±³À°½Ã°£ 11¿ù 08ÀÏ ±×·£µåº¼·ë 14:20~14:30 Recorded live + Q&A  Á¤¿µ±Õ(±¸¹Ì¼öÈäºÎ¿Ü°ú) 
±³À°½Ã°£ 11¿ù 08ÀÏ ±×·£µåº¼·ë 14:30~14:40 Paget-Schroetter syndrome: what is the best management?  ¾ç½Å¼®(»ï¼º¼­¿ïº´¿ø) 
±³À°½Ã°£ 11¿ù 08ÀÏ ±×·£µåº¼·ë 14:40~14:50 anticonagulation therapy after acute DVT  ÇѾƶ÷(¼­¿ï´ëº´¿ø) 
±³À°½Ã°£ 11¿ù 08ÀÏ ±×·£µåº¼·ë 14:50~15:00 Difficult retrieval of IVC filter: Tips and Tricks  ÀÓ³²¿­(±¤Á̷ֹ¡ÀÇ¿ø) 
±³À°½Ã°£ 11¿ù 08ÀÏ ±×·£µåº¼·ë 15:00~15:10 Role of major RCTs: CAVENT, ATTRACT & DUTCH CAVA  ±è¾ç±â(¼øõÇâ´ë ¼­¿ïº´¿ø) 
È޽Ġ11¿ù 08ÀÏ ±×·£µåº¼·ë 15:10~15:20 Coffee Break  () 
±³À°½Ã°£ 11¿ù 08ÀÏ ±×·£µåº¼·ë 15:20~15:30 Postprocedural evaluations of VenaSeal¢â Closure System  ¹ÚÀμö(ÂüÇÏÁö¿Ü°ú) 
±³À°½Ã°£ 11¿ù 08ÀÏ ±×·£µåº¼·ë 15:30~15:40 Recorded live + Q&A  ¹ÚÀμö(ÂüÇÏÁö¿Ü°ú) 
±³À°½Ã°£ 11¿ù 08ÀÏ ±×·£µåº¼·ë 15:40~15:50 Postprocedural evaluations of ClariVein¢ç  ÀüÈñÀç(ÀüÈñÀçÈäºÎ¿Ü°ú) 
±³À°½Ã°£ 11¿ù 08ÀÏ ±×·£µåº¼·ë 15:50~16:00 Recorded live + Q&A  ÀüÈñÀç(ÀüÈñÀçÈäºÎ¿Ü°ú) 
±âŸ 11¿ù 08ÀÏ ±×·£µåº¼·ë 16:00~16:20 Closing Address (Çмú»ó ¹× ¿ì¼ö³í¹® Æ÷»ó)  À±»ó¼·(´ëÇÑÁ¤¸ÆÇÐȸ ÀÌ»çÀå) 
ÆÄ¿ö¸µÅ© ±¤°íµî·Ï
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
¸Þµð¾÷
" 2020 Á¦39ȸ ´ëÇÑÁ¤¸ÆÇÐȸ Ãß°èÇмú´ëȸ : 2020-11-08""ÀÇ ÀÌ¿ëÈı⳪ Ãßõ´ñ±ÛÀ» ³²°Ü À¯¿ëÇÑ Á¤º¸·Î °øÀ¯ÇսôÙ. ^^
¡å
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
 
¸ñ·Ï ¼öÁ¤ »èÁ¦
ÀÌÀü±Û (¿Â¶óÀÎ)Á¦8ȸ ´ëÇѼҾÆÀ̺ñÀÎÈÄ°úÇÐȸ ±³À°°­Á : 2020-11-08
´ÙÀ½±Û (¿Â¶óÀÎ) 2020³â ´ëÇÑ¿Ü°úÀÇ»çȸ Ã߰迬¼ö°­Á : 2020-11-08
¹øÈ£ Á¦¸ñ Ãßõ Á¶È¸ µî·ÏÀÏ
435 ¼­¿ï ´ëÇÑ´ç´¢º´ÇÐȸ The 17th Postgraduate Course of Diabetes : 2018-09-15 0 845 2018-08-15
434 ÃæºÏ Á¦11Â÷ ´ëÇÑÁßÀçÇ÷°ü¿Ü°úÇÐȸ ½ÉÆ÷Áö¾ö : 2018-09-15 0 878 2018-08-15
433 Á¦ÁÖ ´ëÇÑÄ¡·áÃÊÀ½ÆÄÇÐȸ Á¦4ȸ Á¤±âÇмú´ëȸ : 2018-09-14 0 962 2018-08-15
432 ¼­¿ï Á¦74Â÷ ´ëÇÑ¿µ»óÀÇÇÐȸ Çмú´ëȸ(KCR 2018) 3ÀÏÂ÷ : 2018-09-14 0 2,506 2018-08-15
431 °æ³² ´ëÇÑÁø´Ü°Ë»çÀÇÇÐȸ ¿µ³²ÁöºÎ 2018³â 9¿ù Áý´ãȸ : 2018-09-14 0 969 2018-08-15
430 °æ±â ±¹¸³¾Ï¼¾ÅÍ 2018³â 3Â÷ ÀÇ»ý¸í°úÇÐÆ÷·³ : 2018-09-14 0 765 2018-08-15
429 ¼­¿ï °¡Å縯´ëÇб³¼­¿ï¼º¸ðº´¿ø °³¿øÀÇ ¿¬¼ö±³À° : 2018-09-14 0 627 2018-08-15
428 ÃæºÏ Á¦11Â÷ ´ëÇÑÁßÀçÇ÷°ü¿Ü°úÇÐȸ ½ÉÆ÷Áö¾ö : 2018-09-14 0 1,482 2018-08-15
427 ¼­¿ï Á¦74Â÷ ´ëÇÑ¿µ»óÀÇÇÐȸ Çмú´ëȸ(KCR 2018) 2ÀÏÂ÷ : 2018-09-13 0 1,545 2018-08-15
426 ¼­¿ï ÀÎÁ¦´ëÇб³»ó°è¹éº´¿ø À̺ñÀÎÈÄ°ú Áý´ãȸ : 2018-09-11 0 508 2018-08-15
425 °æ±â ÇѾç´ëÇб³±¸¸®º´¿ø °©»ó¼± Á¾¾çÀÇ Áø´Ü°ú Ä¡·á: Ãֽŵ¿Çâ : 2018-09-11 0 453 2018-08-15
424 ºÎ»ê Á¦493Â÷ ´ëÇѸ¶ÃëÅëÁõÀÇÇÐȸ ºÎ»êÁöȸ Áý´ãȸ : 2018-09-10 0 508 2018-08-15
423 ¼­¿ï °¡Å縯´ëÇб³ ÀÇ°ú´ëÇÐ Á¦ 12ȸ °¡Å縯¼ºÇü½ÉÆ÷Áö¾ö : 2018-09-09 0 791 2018-08-15
422 ¼­¿ï Á߾Ӵ뺴¿ø È£Èí±â¾Ë·¹¸£±â³»°ú ¿¬¼ö°­Á : 2018-09-09 1 793 2018-08-15
421 ¼­¿ï ´ëÇѼºÇü¿Ü°úÇÐȸ Ç׳ëÈ­¼ºÇü¿¬±¸È¸ Á¦4ȸ ½ÉÆ÷Áö¾ö : 2018-09-09 0 805 2018-08-15
1381 | 1382 | 1383 | 1384 | 1385 | 1386 | 1387 | 1388 | 1389 | 1390
 
Ä¿¹Â´ÏƼ
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ë¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
º´¿øȨÆäÀÌÁö
¸ÞµðÅå
ÇÑÀÇ¿ø
¼ºÇü¿Ü°ú
Ä¡°ú
¾È°ú
¿©¼ºº´¿ø
³»°ú
Á¤Çü¿Ü°ú
ÇǺΰú
¼Ò¾Æ°ú
À̺ñÀÎÈÄ°ú
ºñ´¢ÀÇÇаú
¿ä¾çº´¿ø
ÀçÈ°ÀÇÇаú
µ¿¹°º´¿ø
±âŸº´ÀÇ¿ø
Ãë¾÷°ü·Ã
Áö¿ø¼­¾ç½Ä
¼­·ù¾ç½Ä
¸Þµð¾÷ ¸ð¹ÙÀÏÀ¥
¸Þµð¾÷